title: [The 2-chloride adenosine alleviates the damage of brain tissues in pentylenetetrazole-kindled epileptic mice by regulating P-glycoprotein expression].
abstract: Objective To observe the changes of expression of P-glycoprotein (PGP) in the brain of pentylenetetrazole (PTZ)-kindled epileptic mice after 2-chloride adenosine (2-CAdo) stimulation. Methods The C57BL/6 mice (n=40) were randomly divided into three groups: control group (n=8), PTZ group (n=16) and 2-CAdo group (n=16). The epileptic model was established by intraperitoneal injection of PTZ [30 mg/(kg.d)]. The control group were given the same amount of normal saline. The seizures were observed during PTZ kindling (kindling rate, latency time, start time and durations of seizures). After kindled, the 2-CAdo group was continuously injected with 2-CAdo [0.6 mg/(kg.d)] for 2 weeks. The other two groups were injected with normal saline instead. Then, all the mice of these three groups were sacrificed. HE staining was adopted to observe the histopathological changes of cerebral cortex and hippocampus of the mice, and the expression of PGP was detected by immunohistochemistry and Western blotting. Results At the time of seizures, the mice showed whole body tremor, hair erection, apathy, loss of appetite, cage offense and other abnormalities. HE staining showed that the damage of cerebral cortex and hippocampus of the 2-CAdo group was less than that of the PTZ group. Immunohistochemistry and Western blotting showed that the expression of PGP in the cerebral cortex of the 2-CAdo group was significantly lower than that in the control and PTZ groups. In the hippocampus, the expression of PGP in the 2-CAdo and PTZ groups was significantly higher than that in the control group, especially highest in the 2-CAdo group. Conclusion The 2-CAdo can reduce the damage of brain tissue, upregulate the expression of PGP in the hippocampus, and downregulate the expression of PGP in the cerebral cortex.
authors.affiliation: Department of Neurology, Wuhan No.1 Hospital, Wuhan 430022, China.
authors.forename: Ping
authors.initials: P
authors.lastname: Shan
authors.affiliation: Department of Neurology, Wuhan No.1 Hospital, Wuhan 430022, China.
authors.forename: Yulan
authors.initials: Y
authors.lastname: Gou
authors.affiliation: Department of Neurology, Wuhan No.1 Hospital, Wuhan 430022, China.
authors.forename: Lijun
authors.initials: L
authors.lastname: Luo
authors.affiliation: Department of Emergency, Wuhan No.1 Hospital, Wuhan 430022, China. *Corresponding author, E-mail: zhangjilong73@163.com.
authors.forename: Jilong
authors.initials: J
authors.lastname: Zhang
authors.affiliation: Department of Neurology, Tongji Hospital, Huazhong University of Science & Technology, Wuhan 430030, China.
authors.forename: Suiqiang
authors.initials: S
authors.lastname: Zhu
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000235:genetics* / Q000378:metabolism; D000241:Adenosine / Q000008:administration & dosage* / Q000737:chemistry; D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D004827:Epilepsy / Q000139:chemically induced / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D010433:Pentylenetetrazole / Q000009:adverse effects
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000241:Adenosine; D010433:Pentylenetetrazole